Diagnostic dilemmas in amyotrophic lateral sclerosis

Journal of the Neurological Sciences

Volumn 165, Issue SUPPL. 1, 1999, Pages

  Brooks, B R ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Anatomical level of involvement; Early diagnosis; El Escorial criteria

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; AUTOPSY; CONFERENCE PAPER; ELECTROMYOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NERVE CONDUCTION; NEUROPATHOLOGY; PRIORITY JOURNAL;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOPSY; BRAIN; DIAGNOSIS, DIFFERENTIAL; ELECTROMYOGRAPHY; HUMANS; MEDICAL RECORDS; NEUROLOGIC EXAMINATION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 0032801298     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00019-2     Document Type: Conference Paper

References (36)

1. Tucker T, Layzer RB, Miller RG, Chad D. Subacute, reversible motor neuron disease. Neurology 1991;41:1541-4.
2. Bonduelle M. Amyotrophic lateral sclerosis. In: Vinken PJ, Bruyn GW, editors, Handbook of clinical neurology, Vol. 22, Amsterdam: North-Holland, 1975, pp. 281-338, Chapt. 13.
3. Hoffman PM, Brody JA. The reliability of death certificate reporting for amyotrophic lateral sclerosis. J Chron Dis 1971;24:5-8.
4. Li T, Swash M, Alberman E, Day S. Diagnosis of motor neuron disease by neurologists: a study in three countries. J Neurol Neurosurg Psychiatry 1991;54:980-3.
5. Li T, Day S, Alberman E, Swash M. Differential diagnosis of motoneuron disease from other neurological conditions. Lancet 1986;2:731-3.
6. El Escorial Working Group. Criteria for the diagnosis of amyotrophic lateral sclerosis. World Neurol 1990;5(1):12.
7. Subcommittee on Motor Neuron Diseases of the World Federation of Neurology Research Group on Neuromuscular Diseases, El Escorial 'Clinical Limits of ALS' Workshop Contributors. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124:96-107.
8. Tierney M, Fisher R, Lewis A, Zorzitto M, Snow W, Reid D, Nieuwstraten P. The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathological study of 57 cases. Neurology 1988;38:359-64.
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
10. Morris J, McKeel D, Fulling K, Torack R, Berg L. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol 1988;24:17-22.
11. Lawyer T, Netsky M. Amyotrophic lateral sclerosis: a clinicoanatomic study of 53 cases. Arch Neurol Psychiatry 1953;69:171-92.
12. Engel WK, Kurland LT, Klatzo I. An inherited disease similar to amyotrophic lateral sclerosis with a pattern of posterior column involvement. An intermediate form? Brain 1959;82:203-20.
13. Hughes T. Pathology of amyotrophic lateral sclerosis. In: Rowland LP, editor, Human motor neuron diseases, New York: Raven Press, 1982, pp. 61-74.
14. Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism, and other neurological disorders: a review. Brain 1981;104:217-47.
15. Davidson C, Wechsler IS. Amyotrophic lateral sclerosis with involvement of posterior columns and sensory disturbances. Arch Neurol Psychiatry 1936;35:229-39.
16. Chou S. Pathology: light microscopy of amyotrophic lateral sclerosis. In: Smith RA, editor, Handbook of amyotrophic lateral sclerosis, New York: Marcel Dekker, 1992, pp. 133-81.
17. Horoupian DS, Thai L, Katzman R, Terry RD, Davis P, Hirano A, DeTeresa R, Fuld PA, Petito C, Blass J, Ellis JM. Dementia and motor neuron disease: morphometric, biochemical, and golgi studies. Ann Neurol 1984;16:305-13.
18. Mackay RP. Course and prognosis in amyotrophic lateral sclerosis. Arch Neurol 1963;8:117-27.
19. Davidson CD. Amyotrophic lateral sclerosis: origin and extent of the upper motor neuron lesion. Arch Neurol 1941;46:1039-56.
20. Sobue G, Sahashi K, Takahashi A, Matsuoko Y, Muroga T, Sobue I. Degenerating compartment and functioning compartment of motor neurons in amyotrophic lateral sclerosis. Neurology 1983;33:654-7.
21. Swash M, Schultz CL, Vowles G, Ingram DA. Selective and asymmetric vulnerability of corticospinal and spinocerebellaer tracts in motor neuron disease. J Neurol Neurosurg Psychiatry 1988;51:785-9.
22. Hudson AJ. The motor neuron diseases and related disorders. In: Joynt RJ, editor. Clinical neurology. 1991, pp. 1-35, Chapt. 53A.
23. Hirano A. Pathology of amyotrophic lateral sclerosis. In: Gajdusek DC, Gibs CJ, editors, Slow, latent, and template virus infection, Washington, DC: NINDB, 1965, pp. 23-37.
24. Hirano A, Iwata M. Pathology of motor neurons with special reference to amyotrophic lateral sclerosis and related diseases. In: Tsubki T, Toyokura Y, editors, Amyotrophic lateral sclerosis, Baltimore: University Park Press, 1979, pp. 107-33.
25. Malamud N. Neuromuscular diseases. In: Minckler J, editor, Pathology of the nervous system, New York: McGraw-Hill, 1968, pp. 712-25.
26. Bertrand I, VanBogaert L. Rapport sur la sclerose laterale amyotrophique (anatomie pathologique). Rev Neurol 1925;1:779-806.
27. Brownell B, Oppenheimer DR, Hughes TR. The central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry 1970;33:338-57.
28. Friedman AP, Freedman D. Amyotrophic lateral sclerosis. J Nerv Ment Dis 1950;3:1-18.
29. Wohlfart G, Swank RL. Pathology of amyotrophic lateral sclerosis: fiber analysis of the ventral roots and pyramidal tracts of the spinal cord. Arch Neurol Psychiatry 1941;46:783-99.
30. Smith M. Nerve fiber degeneration in the brain in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1960;23:269-92.
31. Guiloff RJ, McGregor B, Thompson E, Blackwood W, Paul E. Motor neurone disease with elevated cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1980;43:390-6.
32. Hirano A, Arumugasamy N. Amyotrophic lateral sclerosis: a comparison of Guam and classical cases. Arch Neurol 1967;16:357-63.
33. Holmes G. The pathology of amyotrophic lateral sclerosis. Rev Neurol Psychiatry 1909;8:693-725.
34. Brooks BR, Sufit RL, DePaul R, DeTan Y, Sanjak M, Robbins J. Design of clinical therapeutic trials in amyotrophic lateral sclerosis. In: Rowland LP, editor, Amyotrophic lateral sclerosis and other motor neuron diseases, New York: Raven Press, 1991, pp. 521-45.
35. Younger DS, Rowland LP, Latov N, Sherman W, Pesce M, Lange DJ, Trojaborg W, Miller JR, Lovelace RE, Hays AP, Kim TS. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology 1990;40:595-9.
36. Petkau A, Sawatzky A, Hillier R, Hoogstraten J. Lead content of neuromuscular tissue in amyotrophic lateral sclerosis: case report and other considerations. Br J Ind Med 1974;31:275-87.